June 8, 2022 Experience Dynamics Special Purpose Corp. completed combination with Senti Biosciences We advised Dynamics Special Purpose Corp. on this transaction
June 7, 2022 Experience InSilico Medicine $60 million Series D financing We are advising InSilico Medicine in connection with its $60 million Series D financing
May 31, 2022 Experience GSK $3.3 billion acquisition of Affinivax We are advising GSK on the acquisition
April 27, 2022 Experience Acutus Medical sale of its left-heart access portfolio products We are advising Acutus Medical on the transaction
April 27, 2022 Experience Ingenovis Health acquisition of VISTA Staffing Solutions We are advising Ingenovis Health, Cornell Capital and Trilantic on the transaction
April 18, 2022 Experience Natus Medical $1.2 billion acquisition by ArchiMed We are advising Natus Medical on the transaction
April 6, 2022 Experience Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings We advised Charles River on the transaction
February 11, 2022 Experience Signify Health $250 million acquisition of Caravan Health We are advising Signify Health on the transaction
January 20, 2022 Experience Silver Spike Acquisition Corp. II combination with Eleusis We are advising the SPAC on the transaction